Clinical Trials Directory

Trials / Completed

CompletedNCT00629044

Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD

Etude du Polymorphysme génétique de la cholestérol 24S Hydroxylase et Des Teneurs en 24S hydroxycholestérol Chez Des Patients Atteints de Glaucome ou de dégénérescence Maculaire liée à l'âge.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
320 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to assess the implicitement of the cholesterol 24 S hydroxylase gene and the 24 S hydroxycholesterol in glaucoma and in age related macular degeneration.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAssessing the blood level of cholesterol 24 S HydroxylaseComparison of venous blood level of Cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with Glaucoma and AMD and in healthy subjects.
BIOLOGICALAssessing the blood level of cholesterol 24 S hydroxylaseComparison of venous blood level of cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with Glaucoma, AMD end in healthy subjects
BIOLOGICALassessing the blood level of cholesterol 24 S hydroxylaseComparison of venous blood level of cholesterol 24 S hydroxylase and 24 hydroxycholesterol in patients with glaucoma, AMD and in healthy subjects

Timeline

Start date
2007-11-01
Primary completion
2009-11-01
Completion
2011-01-01
First posted
2008-03-05
Last updated
2011-03-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00629044. Inclusion in this directory is not an endorsement.

Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD (NCT00629044) · Clinical Trials Directory